Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

291 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Repaglinide versus glyburide: a one-year comparison trial.
Marbury T, Huang WC, Strange P, Lebovitz H. Marbury T, et al. Among authors: strange p. Diabetes Res Clin Pract. 1999 Mar;43(3):155-66. doi: 10.1016/s0168-8227(99)00002-9. Diabetes Res Clin Pract. 1999. PMID: 10369424 Clinical Trial.
Efficacy and safety of ETC-1002, a novel investigational low-density lipoprotein-cholesterol-lowering therapy for the treatment of patients with hypercholesterolemia and type 2 diabetes mellitus.
Gutierrez MJ, Rosenberg NL, Macdougall DE, Hanselman JC, Margulies JR, Strange P, Milad MA, McBride SJ, Newton RS. Gutierrez MJ, et al. Among authors: strange p. Arterioscler Thromb Vasc Biol. 2014 Mar;34(3):676-83. doi: 10.1161/ATVBAHA.113.302677. Epub 2014 Jan 2. Arterioscler Thromb Vasc Biol. 2014. PMID: 24385236 Clinical Trial.
Impact of active versus usual algorithmic titration of basal insulin and point-of-care versus laboratory measurement of HbA1c on glycemic control in patients with type 2 diabetes: the Glycemic Optimization with Algorithms and Labs at Point of Care (GOAL A1C) trial.
Kennedy L, Herman WH, Strange P, Harris A; GOAL AIC Team. Kennedy L, et al. Among authors: strange p. Diabetes Care. 2006 Jan;29(1):1-8. doi: 10.2337/diacare.29.01.06.dc05-1058. Diabetes Care. 2006. PMID: 16373887 Clinical Trial.
291 results